- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/7084 - Compounds having two nucleosides or nucleotides, e.g. nicotinamide-adenine dinucleotide, flavine-adenine dinucleotide
Patent holdings for IPC class A61K 31/7084
Total number of patents in this class: 726
10-year publication summary
|
50
|
67
|
75
|
81
|
85
|
105
|
97
|
56
|
53
|
31
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Santen Pharmaceutical Co., Ltd. | 601 |
25 |
| Nuvamid SA | 58 |
19 |
| The Board of Regents of the University of Texas System | 2204 |
17 |
| Institute of Organic Chemistry and Biochemistry ASCR,V.V.I. | 37 |
14 |
| Eisai R&D Management Co., Ltd. | 1236 |
14 |
| Hoboomlife Bio-Technology (Shenzhen) Co., Ltd. | 33 |
14 |
| Takeda Pharmaceutical Company Limited | 2714 |
13 |
| Immunesensor Therapeutics, Inc. | 35 |
9 |
| Hangzhou Xingao Biotechnology Co. Ltd | 19 |
9 |
| Merck Sharp & Dohme LLC | 3750 |
9 |
| Innate Tumor Immunity, Inc. | 42 |
8 |
| Board of Regents, The University of Texas System | 5786 |
7 |
| The Regents of the University of Michigan | 4693 |
7 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3369 |
7 |
| Janssen Biotech, Inc. | 1552 |
7 |
| Merck Sharp & Dohme Corp. | 2197 |
6 |
| Centre National de La Recherche Scientifique | 10421 |
6 |
| Glaxosmithkline Intellectual Property Development Limited | 762 |
6 |
| Codiak Biosciences, Inc. | 57 |
6 |
| Institut Curie | 582 |
6 |
| Other owners | 517 |